PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vitalant Research Institute, San Francisco, California, USA.\', \'Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.\', \'Vitalant Research Institute, Denver, Colorado, USA.\', \'Infectious Disease and Microbiome Program, Broad Institute of MIT & Harvard, Cambridge, Massachusetts, USA.\', \'Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.\', \'Vitalant, Scottsdale, Arizona, USA.\', \'University of Colorado School of Medicine, Aurora, Colorado, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/trf.16555
?:doi
?:hasPublicationType
?:journal
  • Transfusion
is ?:pmid of
?:pmid
?:pmid
  • 34121205
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.645
?:rankingScore_hIndex
  • 120
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all